(Q36953425)

17 August 2017

1 reference

title

Treatment of breast cancer in older women (English)

1 reference

17 August 2017

Daniele Bernardi

1

1 reference

17 August 2017

Domenico Errante

2

1 reference

17 August 2017

Enzo Gallligioni

3

1 reference

17 August 2017

Diana Crivellari

4

1 reference

17 August 2017

Antonio Bianco

5

1 reference

17 August 2017

Luigi Salvagno

6

1 reference

17 August 2017

Ian S Fentiman

7

1 reference

17 August 2017

publication date

1 January 2008

1 reference

17 August 2017

1 reference

17 August 2017

volume

47

1 reference

17 August 2017

issue

2

1 reference

17 August 2017

page(s)

187-198

1 reference

Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Breast cancer and aging. Clinical interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Breast cancer treatment guidelines in older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Never too old? Age should not be a barrier to enrollment in cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

The need for targeted research into breast cancer in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Is surgical management compromised in elderly patients with breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

The impact of prophylactic axillary node dissection on breast cancer survival--a Bayesian meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Does sentinel lymphadenectomy improve staging and alter therapy in elderly women with breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Is breast cancer sentinel lymph node mapping valuable for patients in their seventies and beyond?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Breast reconstruction in the elderly: preserving excellent quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Reasons why women who have mastectomy decide to have or not to have breast reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Factors affecting outcome in free-tissue transfer in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Breast reconstruction in older women: advantages of autogenous tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Breast reconstruction in older women: should age be an exclusion criterion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Breast cancer treatment in older women: does getting what you want improve your long-term body image and mental health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Diagnosis and treatment of breast cancer in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Locally advanced breast cancer in octogenarian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the Nationa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Epirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Chemotherapy for older women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: a multinational, double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Use of growth factors in the elderly patient with cancer: a report from the Second International Society for Geriatric Oncology (SIOG) 2001 meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

Effectiveness of Radiation Therapy for Older Women With Early Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701630234

10.1080/02841860701630234

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference